Person

David W. Meline

Director, HP Inc.

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$2.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • MRNA
    Moderna
    Chief Financial Officer
    Jun 2020 – last filing Aug 2022
  • AMGN
    Amgen
    EVP & CFO
    May 2016 – last filing Nov 2019

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 10, 2022MRNASale164$173.66$28K
May 10, 2022MRNASale156$133.71$21K
Feb 10, 2022MRNASale619$158.89$98K
Nov 25, 2019AMGNSale8,737$234.36$2.0M

SEC reporting-owner ID (CIK) 1444612 · all filings on EDGAR

David W. Meline (HPQ) | USBoard